Skip to main content
. 2021 Jun 29;12:3889. doi: 10.1038/s41467-021-24151-3

Fig. 5. Proposed transport mechanism for HMW drugs bypassing the DBP.

Fig. 5

Top view on the AcrB porter domain. Only the α-helical part of the PC1 and PC2 subdomains is shown (blue, L protomer; yellow, T protomer, red, O protomer). Binding of rifampicin-type (top row) and rifabutin/macrolide-type (bottom row) drugs to the access pocket (AP) is shown from left to right. The switch loop is colored in magenta. The dotted boundary of the ovals represents a closed deep binding pocket (DBP). Red arrow: the movement of switch loop. For further discussion on the mechanism see main text and Supplementary Note 2.5. PDB IDs of the displayed protomer structures: L, O: 4DX5; L3-FOR: 6ZOB; LERY: 6ZOC; TLIG1: 6ZO7; TLIG2*, TLIG3: 6ZO9.